Acadia Pharmaceuticals (ACAD) EBIT (2010 - 2026)
Acadia Pharmaceuticals' EBIT was $37.84 million in Q2 2026, up 16.9% from $32.37 million a year earlier.
Powered by 
Analysis
Acadia Pharmaceuticals (ACAD) EBIT (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Acadia Pharmaceuticals' EBIT was $86.37 million through Jun 30, 2026, down 63.5% year-over-year; for FY2025, it came in at $104.81 million, down 54.6% from FY2024.
- In earlier years, EBIT was $230.79 million in FY2024, -$73.38 million in FY2023, -$223.6 million in FY2022 and -$170.44 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBIT since Q4 2024.
- Compared with a year earlier, EBIT was higher in five of the last six quarters, with growth averaging 52.3%.
- Per Business Quant data, ACAD's EBIT in the three quarters before Q2 2026 was -$4.62 million (Q1 2026), $17.39 million (Q4 2025) and $35.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.17 Bn | 1,102.76 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 615.84 Bn | 534.36 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 500.69 Bn | 473.80 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 367.34 Bn | 321.72 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.61 Bn | 261.60 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.75 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 235.51 Bn | 190.91 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 190.60 Bn | 164.80 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 169.37 Bn | 116.02 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Acadia Pharmaceuticals | 3.47 Bn | -534,120.99 | 279.64 Mn | 37.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.84 Mn |
| Mar 31, 2026 | -4.62 Mn |
| Dec 31, 2025 | 17.39 Mn |
| Sep 30, 2025 | 35.76 Mn |
| Jun 30, 2025 | 32.37 Mn |
| Mar 31, 2025 | 19.29 Mn |
| Dec 31, 2024 | 153.50 Mn |
| Sep 30, 2024 | 31.64 Mn |
| Jun 30, 2024 | 30.44 Mn |
| Mar 31, 2024 | 15.21 Mn |
| Dec 31, 2023 | 34.94 Mn |
| Sep 30, 2023 | -57.78 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | -53.58 Mn |
| Dec 31, 2022 | -46.06 Mn |
| Sep 30, 2022 | -30.87 Mn |
| Jun 30, 2022 | -33.65 Mn |
| Mar 31, 2022 | -113.02 Mn |
| Dec 31, 2021 | -44.66 Mn |
| Sep 30, 2021 | -15.30 Mn |
API Access
Acadia Pharmaceuticals EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=ACAD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "ACAD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=ACAD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();